SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-006292
Filing Date
2023-10-24
Accepted
2023-10-24 16:18:27
Documents
14
Period of Report
2023-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187221-8k_inmedpharm.htm   iXBRL 8-K 34964
2 NEWS RELEASE, DATED OCTOBER 24, 2023 ea187221ex99-1_inmedpharm.htm EX-99.1 34857
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5078
  Complete submission text file 0001013762-23-006292.txt   259280

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20231024.xsd EX-101.SCH 3021
4 XBRL LABEL FILE inm-20231024_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20231024_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea187221-8k_inmedpharm_htm.xml XML 3444
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 231342891
SIC: 2834 Pharmaceutical Preparations